Algreen (ALGRE.PA)

Algreen (ALGRE.PA) — VMCI valuation read

ALGRE.PA screens at VMCI 39/100, a 11-point gap below the Consumer Defensive sector median (50). For a mid-cap Algreen share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

ALGRE.PA has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: ALGRE.PA trades at 14.0x earnings, 22% below the Consumer Defensive median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Consumer Defensive group. Quality: ROIC of 12.0% sits 2.0pp above the Consumer Defensive median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -1.4x leaves covenant headroom, which sets the rate-cycle exposure for Algreen.

ALGRE.PA fell 1.6% over the trailing 7 days, with a -1.4% read on a 30-day basis.